Bilcare Solutions launches new laminating line in Bötzingen, Germany
The decision to extend the Pharma Packaging Innovations (PPI) business by producing laminated barrier films at the Bilcare facilities in Bötzingen, Germany, marks a further step in offering integrated solutions for the global pharmaceutical industry.
As of now, FDA-compliant multi-layer barrier films will be produced under GMP conditions with the new state of the art, DIN EN ISO 15378 validated laminating line. This makes Bilcare Solutions the sole provider of high-barrier films in Europe, offering in house production of barrier films from the actual manufacturing over lamination to coating, all under one umbrella.
"With the investment in this new laminating line, we consequently continue to implement our growth strategy and strengthen our leading position as integrated system provider for mono-, duplex- and triplex films for the pharmaceutical industry," comments Thorsten Kühn, CEO Bilcare Research AG, Switzerland.
Bilcare Research GmbH
Bilcare Solutions (www.bilcaresolutions.com) is alongside with the businesses Global Clinical Supplies und Bilcare Technologies part of the Bilcare Research Group (www.bilcare.com) which operates 13 sites with 2,300 employees worldwide. Bilcare Solutions is a global producer of rigid films. Its manufacturing and marketing activity is concentrated in the production of rigid PVC and PVC-PE films and includes the finishing of films in the form of coating, stentering, laminating and metallizing. The company is also involved in the extrusion of PET-films. With over 50 years experience in the production of rigid films, Bilcare Solutions today is one of the leading rigid film producers in the world. Worldwide the company employs approximately 1,300 people with sites in Germany, Italy, India, Singapore, UK and USA. It has the capacity to produce around 120,000 tonnes of films per annum and had sales of EUR 270 million in 2010.